Lyell Immunopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 332 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 326-332 of 332 matching filings.

Per page
25
Current page
14
UPLOAD

UPLOAD filing

Filing date
25 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-256470

S-1

Filing date
25 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
12 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-04650

DRS/A filing

Filing date
12 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-04650

DRS filing

Filing date
12 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-363351

D filing

Filing date
20 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .